Towards Healthcare
Cell and Gene Therapy Infrastructure Market Growth Forecast 2025 to 2034

Cell and Gene Therapy Infrastructure Market Ignites Global Expansion

The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending.

  • Last Updated: 13 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The cell and gene therapy infrastructure market is expected to reach new heights by 2034, driven by technological breakthroughs and changing consumer preferences.

North America is currently leading the cell and gene therapy infrastructure market due to extensive research and development (R&D) investments.

Some key players include Ori Biotech, Miltenyi Biotec, Akron Biotech, BioSpherix, Cellinoand QuickSTAT.

Cell and gene therapy are cutting-edge medical approaches that treat diseases by altering or replacing the genes within a patient cells or by introducing healthy cells to the body.

Ministry of Health and Family Welfare, FDA, WHO, PIB, CDC.